Author, year | Body part | Total sample size | Sample size with autopsy | Excluded | TP | FN | FP | TN | Sensitivity, % (95% CI)* | Specificity, % (95% CI)* | ||
ND autopsy | ND PMUS | No autopsy | ||||||||||
Neurological | ||||||||||||
Votino et al, 201820 | Brain | 88 | 66 | 17 | 4 | 5 | 10 | 1 | 7 | 48 | 87.5 (59.8 to 97.1) | 86.6 (75.3 to 93.2) |
Prodhomme et al, 201510 | Brain | 169 | 169 | 0 | 0 | NA | 84 | 10 | 0 | 75 | 88.9 (81.1 to 93.8) | 99.3 (94.0 to 99.9) |
Tuchtan et al, 201819 | Brain | 75 | 75 | 0 | 0 | NA | 22 | 5 | 1 | 47 | 80.4 (62.4 to 91.0) | 96.9 (87.8 to 99.3) |
Prodhomme et al, 201510 | Spine | 169 | 169 | 0 | 0 | NA | 18 | 0 | 0 | 151 | 97.4 (79.1 to 99.7) | 99.6 (96.9 to 100.0) |
Tuchtan et al, 201819 | Spine | 75 | 75 | 0 | 0 | NA | 10 | 0 | 0 | 65 | 95.5 (67.9 to 99.5) | 99.2 (93.1 to 99.9) |
Kang et al, 201917 | Brain and spine | 123 | 70 | 53 | 13 | NA | 13 | 8 | 11 | 38 | 61.4 (40.8 to 78.5) | 77.0 (63.7 to 86.5) |
Cardiothoracic | ||||||||||||
Prodhomme et al, 201510 | Thoracic | 169 | 169 | 0 | 0 | NA | 10 | 1 | 0 | 158 | 87.5 (59.8 to 97.1) | 99.7 (97.1 to 100.0) |
Kang et al, 201917 | Thoracic | 123 | 123 | 0 | 21 | NA | 5 | 14 | 20 | 84 | 27.5 (12.8 to 49.4) | 80.4 (71.9 to 87.0) |
Tuchtan et al, 201819 | Thoracic | 75 | 75 | 0 | 0 | NA | 6 | 2 | 0 | 67 | 72.2 (40.2 to 91.0) | 99.3 (93.3 to 99.9) |
Prodhomme et al, 201510 | Cardiac | 169 | 169 | 0 | 0 | NA | 2 | 9 | 0 | 158 | 20.8 (6.7 to 49.1) | 99.7 (97.1 to 100.0) |
Kang et al, 201917 | Cardiac | 123 | 122 | 1 | 24 | NA | 13 | 13 | 18 | 78 | 50.0 (32.4 to 67.6) | 81.0 (72.0 to 87.5) |
Tuchtan et al, 201819 | Cardiac | 75 | 75 | 0 | 0 | NA | 4 | 18 | 0 | 53 | 19.6 (8.3 to 39.5) | 99.1 (91.7 to 99.9) |
Votino et al, 201820 | Cardiac and thoracic | 88 | 88 | 0 | 2 | NA | 16 | 2 | 5 | 65 | 86.8 (65.5 to 95.8) | 92.3 (83.7 to 96.5) |
Abdominal | ||||||||||||
Votino et al, 201820 | Whole abdomen | 88 | 88 | 0 | 2 | NA | 12 | 2 | 4 | 70 | 83.3 (58.4 to 94.7) | 94.0 (86.2 to 97.5) |
Kang et al, 201917 | Whole abdomen | 123 | 123 | 0 | 19 | NA | 17 | 11 | 23 | 72 | 60.3 (42.4 to 75.9) | 75.5 (66.0 to 83.0) |
Prodhomme et al, 201510 | Gastrointestinal | 169 | 169 | 0 | 0 | NA | 15 | 10 | 0 | 144 | 59.6(40.7 to 76.0) | 99.7 (96.8 to 100.0) |
Tuchtan et al, 201819 | Gastrointestinal | 75 | 75 | 0 | 0 | NA | 2 | 0 | 1 | 72 | 83.3 (31.0 to 98.2) | 98.0 (91.7 to 99.5) |
Prodhomme et al, 201510 | Urinary system | 169 | 169 | 0 | 0 | NA | 37 | 2 | 0 | 130 | 93.7 (81.8 to 98.0) | 99.6 (96.4 to 100.0) |
Tuchtan et al, 201819 | Urinary system | 75 | 75 | 0 | 0 | NA | 9 | 1 | 0 | 65 | 86.4 (57.1 to 96.8) | 99.2 (93.1 to 99.9) |
*Sensitivities, specificities and associated 95% CI are calculated using the standard univariate approach while making an adjustment of 0.5 for zero frequencies where necessary.
FN, false negative; FP, false positive; NA, not applicable; ND, non-diagnostic; PMUS, post-mortem ultrasound; TN, true negative; TP, true positive.